Please login to the form below

Not currently logged in
Email:
Password:

job losses

This page shows the latest job losses news and features for those working in and with pharma, biotech and healthcare.

MSD hangs ‘for sale’ sign on French facility, shedding 207 staff

MSD hangs ‘for sale’ sign on French facility, shedding 207 staff

Job losses will be across manufacturing and R&D divisions. Merck &Co/MSD has set another part of its ongoing cost-cutting drive in motion, announcing the closure of a plant ... in France that will result in 207 job losses across manufacturing and R&D.

Latest news

More from news
Approximately 1 fully matching, plus 71 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Three strategies for managing loss of exclusivity successfully

    Patent losses could sink Allergan”. 1. “Drug prices to plummet in wave of expiring patents”. ... 4. It’s no wonder “loss of exclusivity (LOE)” or “the patent cliff” is an ominous prospect for drug manufacturers – shrouded in the threat

  • Three strategies for managing loss of exclusivity successfully

    Patent losses could sink Allergan”. “Drug prices to plummet in wave of expiring patents”. ... patent cliff” is an ominous prospect for drug manufacturers – shrouded in the threat of job losses and falling share prices.

  • Artificial Intelligence in healthcare

    However, AI is not without its critics, with concerns including job losses where human input is no longer required, or sometimes involve deeper concerns as to the ethics intrinsic to AI. ... As mentioned earlier, job losses are also a concern. Media

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...